Singapore markets close in 2 hours 59 minutes
Straits Times Index
3,267.63 -32.41 (-0.98%) Nikkei
38,273.63 -561.47 (-1.45%) Hang Seng
18,399.89 -79.48 (-0.43%) FTSE 100
8,313.67 +100.18 (+1.22%) Bitcoin USD
62,606.46 -903.75 (-1.42%) CMC Crypto 200
1,298.97 +4.29 (+0.33%)
Veracyte, Inc. (VCYT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 20.92 |
| Open | 20.94 |
| Bid | 20.97 x 100 |
| Ask | 21.09 x 100 |
| Day's range | 20.65 - 21.16 |
| 52-week range | 18.61 - 30.52 |
| Volume | |
| Avg. volume | 696,767 |
| Market cap | 1.608B |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.02 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.83 |
- GuruFocus.com
Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance
Robust Growth in Testing Revenue Drives Positive Financial Outcomes
Business WireVeracyte Announces First Quarter 2024 Financial Results
SOUTH SAN FRANCISCO, Calif., May 07, 2024--Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024.
Business Wire14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
SOUTH SAN FRANCISCO, Calif., May 06, 2024--14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients
© 2024 Yahoo. All rights reserved.